West Grove, PA, United States of America

Anna Hull




Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Hull - Innovator in Immunoglobulin Production

Introduction

Anna Hull is a prominent inventor based in West Grove, Pennsylvania. She has made significant contributions to the field of immunology through her innovative work in antibody production. Her research focuses on the development of compositions and methods for the production of immunoglobulins, which are crucial for various therapeutic applications.

Latest Patents

Anna Hull holds a patent for "Compositions and methods for production of immunoglobulins." This invention provides oligonucleotides for isolating human antibody cDNAs from cells or cell lines, such as hybridomas. The patent includes cDNAs that encode specific complementarity-determining regions (CDRs) of human monoclonal antibodies that bind to protective antigens and lethal factors. Additionally, the invention encompasses expression vectors, host cells, and transgenic plants and animals that express these cDNAs. The patent also details antibody compositions produced through these methods and includes kits for production and use.

Career Highlights

Anna Hull is associated with Ibio Limited, where she continues to advance her research in immunoglobulin production. Her work has the potential to impact the development of therapeutic antibodies, which are essential in treating various diseases.

Collaborations

Anna collaborates with notable colleagues, including Vidadi Yusibov and Vadim Mett, who contribute to her research efforts and enhance the scope of her work in immunology.

Conclusion

Anna Hull is a dedicated inventor whose work in immunoglobulin production is paving the way for advancements in therapeutic applications. Her innovative approaches and collaborations are instrumental in the ongoing development of effective antibody therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…